Related Experiment Videos
[Double-blind randomized study comparing ioversol 300 versus iopromide 300 abdominal computed tomography (CT
H M Hoogewoud1, A C Neiss, B Woessmer
1Département de Radiologie, Hôpital Cantonal, Fribourg, Suisse.
Annales De Radiologie
|January 1, 1992
Summary
Ioversol 300 and iopromide 300 showed similar diagnostic performance and safety in abdominal computed tomography (CT) scans. Both non-ionic contrast agents provided excellent image quality with few side effects.
Area of Science:
- Radiology
- Medical Imaging
Background:
- Contrast agents are crucial for enhancing image quality in computed tomography (CT).
- Non-ionic contrast agents are preferred for their safety profile.
Purpose of the Study:
- To compare the diagnostic performance and safety of ioversol 300 and iopromide 300 in abdominal CT.
- To evaluate image quality and side-effect profiles of these two contrast agents.
Main Methods:
- A randomized, double-blind study was conducted on 79 patients undergoing abdominal CT.
- Patients received either ioversol 300 (41 patients) or iopromide 300 (38 patients).
- Image quality was assessed, and all side effects were recorded.
Main Results:
- No significant differences were observed in image quality between ioversol 300 and iopromide 300.
- Both contrast agents demonstrated a low rate of side effects.
- Excellent image quality was achieved with both ioversol and iopromide.
Conclusions:
- Ioversol is a safe and effective non-ionic contrast agent for contrast-enhanced body CT.
- Iopromide is also a safe and effective option for abdominal CT.
- Both agents offer comparable diagnostic utility and safety.